Why the study?
Does intravenous diltiazem affect cardiac conduction intervals in patients with atherosclerotic heart disease?
Does intravenous diltiazem affect cardiac conduction intervals in patients with atherosclerotic heart disease?
Intravenous diltiazem selectively depresses atrioventricular node conductivity by prolonging the A-H interval, independent of vagal tone.
Answers are grounded in this paper and cite their sources.
May prompt AV conduction monitoring with IV diltiazem in atherosclerotic heart disease; leaves open need for controlled confirmation.
The effects of diltiazem hydrochloride, a new Ca++ antagonistic antianginal drug, on the cardiac conductivity were evaluted in 10 patients with atherosclerotic heart disease. His bundle electrograms were obtained by catheter technique. R-R, A-H and H-V intervals were measured before and after intravenous administration of diltiazem. Diltiazem acted towards significant prolongation in A-H interval. R-R and H-V intervals were insensitive to diltiazem. Diltiazem did not interrupt the cardiac effects of atropine when A-H prolongation was still observed in the subject pretreated with atropine. In short, diltiazem depresses the conductivity of the atrioventricular node selectively and this is not mediated through vagus tone change. This Ca++ antagonist induced A-H prolongation strongly suggests the contribution of Ca++ current on the generation of atrioventricular nodal action potential in humans.
No takes yet. Share an insight, caveat, or question.
Oyama et al. (1978) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: